ELSEN PHARMA
Timeline
46 events since 1992Board
Filings
Financial
Establishments
1995200020052010201520202025
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBabbreviated format · 25 days late
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0446359356
Annual accounts 2024 filed PDFfull format · 60 days late
2024
Highest result from 2006 to 2025 net €525,009 ▲13,202% The operating result of €739,774 and the net result of €525,009 are both a record.
Annual accounts 2023 filed PDFmicro format · 9 days late
2023
Back to profit net €3,947 The net result is €3,947, after one loss-making year.
Annual accounts 2022 filed PDFmicro format · 7 days before the deadline
2022
1 director resigning, 3 reappointmentsReappointments: (managing director), and · Resignation: · General meeting of 18-06-20225 points ▸
- General meeting, 18-06-2022
- Director reappointment, (managing director)
- Director reappointment,
- Director reappointment,
- Director resignation,
Annual accounts 2021 filed PDFmicro format · 4 days late
Annual accounts 2020 filed PDFmicro format · 177 days late
2020
Annual accounts 2019 filed PDFmicro format · 91 days late
2019
Annual accounts 2018 filed PDFmicro format · 30 days late
2018
Equity above €500,000 equity €688,639 After 3 profitable years in a row, equity reaches €688,639.
Annual accounts 2017 filed PDFmicro format · 57 days late
2017
4 directors reappointed, , and · General meeting of 13-10-20175 points ▸
- General meeting, 13-10-2017
- Director reappointment,
- Director reappointment,
- Director reappointment,
- Director reappointment,
Annual accounts 2016 filed PDFmicro format · 65 days late
2016
Back to profit net €29,173 The net result is €29,173, after 2 loss-making years.
Annual accounts 2015 filed PDFfull format · 78 days late
2015
Annual accounts 2014 filed PDFfull format · 31 days late
2014
Weakest financial year net -€226,277 The net result drops to -€226,277, the lowest from 2006 to 2025. It recovers the following year.
Annual accounts 2013 filed PDFfull format · 1 day before the deadline
2013
Back to profit net €37,030 The net result is €37,030, after 7 loss-making years.
Liquidity more than quadruples current ratio 1.42 The current ratio rises from 0.34 to 1.42. Short-term debt falls from €293,555 to €186,727.
Annual accounts 2012 filed PDFfull format · 13 days before the deadline
2012
Annual accounts 2011 filed PDFfull format · 14 days before the deadline
2011
Annual accounts 2010 filed PDFfull format · 23 days late
2010
Annual accounts 2009 filed PDFfull format · 61 days late
2009
Annual accounts 2008 filed PDFfull format · 27 days late
2008
Annual accounts 2007 filed PDFfull format · 22 days late
2007
Annual accounts 2006 filed PDFfull format · 28 days late
2006
Annual accounts 2005 filed PDFfull format
2005
Annual accounts 2004 filed PDFfull format
2004
Annual accounts 2003 filed PDFfull format
2003
Annual accounts 2002 filed PDFfull format
2002
Annual accounts 2001 filed PDFfull format
2001
Annual accounts 2000 filed PDFfull format
2000
Annual accounts 1999 filed PDFfull format
1999
Annual accounts 1998 filed PDFfull format
1998
Annual accounts 1997 filed PDFfull format
1997
Annual accounts 1996 filed PDFfull format
1996
Annual accounts 1995 filed PDFfull format
1995
Annual accounts 1994 filed PDFfull format
1994
Annual accounts 1993 filed PDFfull format
1993
Annual accounts 1992 filed PDFfull format
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank